Alpha 2.0
Login Register
» Articles » PMID: 32467977

Challenges of Community Point-of-care Antibody Testing for COVID-19 Herd-immunity in Japan

Overview
Journal QJM
Specialty General Medicine
Date 2020 May 30
PMID 32467977
Citations 7
Authors
M Takita
T Matsumura
K Yamamoto
E Yamashita
K Hosoda
T Hamaki
E Kusumi
Affiliations
Soon will be listed here.
Citing Articles

Optimizing national border reopening policies in the COVID-19 pandemic: A modeling study.

Huang J, Qian Y, Shen W, Chen Y, Zhao L, Cao S Front Public Health. 2022; 10:979156.

PMID: 36530669 PMC: 9749815. DOI: 10.3389/fpubh.2022.979156.

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.

Nakamura A, Ando S, Endo H, Sato R J Med Virol. 2021; 93(7):4608-4611.

PMID: 33760273 PMC: 8250612. DOI: 10.1002/jmv.26962.

Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.

Nakamura A, Sato R, Ando S, Oana N, Nozaki E, Endo H Fukushima J Med Sci. 2021; 67(1):27-32.

PMID: 33642419 PMC: 8075555. DOI: 10.5387/fms.2020-21.

Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning.

Pecora N, Zand M Clin Lab Med. 2020; 40(4):603-614.

PMID: 33121625 PMC: 7414299. DOI: 10.1016/j.cll.2020.08.014.

Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan.

Lyu Z, Sassa M, Fujitani T, Harada K Diseases. 2020; 8(4).

PMID: 32977485 PMC: 7709119. DOI: 10.3390/diseases8040036.